Cargando…

Cyclosporine A-induced Hair Repigmentation in a Patient with Dermatitis: A Case Report

Cyclosporine A is an immunosuppressant drug known to cause several side effects. One of the most common side effects is hypertrichosis, with a rare presentation of hair repigmentation rarely presenting. Here, we report a case of a 65-year-old Omani male who presented to the dermatology clinic at Rus...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Rajaibi, Raqiya, Al Saadi, Balaqis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OMJ 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148980/
https://www.ncbi.nlm.nih.gov/pubmed/37132003
http://dx.doi.org/10.5001/omj.2023.15
_version_ 1785035077217943552
author Al Rajaibi, Raqiya
Al Saadi, Balaqis
author_facet Al Rajaibi, Raqiya
Al Saadi, Balaqis
author_sort Al Rajaibi, Raqiya
collection PubMed
description Cyclosporine A is an immunosuppressant drug known to cause several side effects. One of the most common side effects is hypertrichosis, with a rare presentation of hair repigmentation rarely presenting. Here, we report a case of a 65-year-old Omani male who presented to the dermatology clinic at Rustaq Polyclinic in Rustaq, Oman, with exfoliative erythroderma. The patient had hair repigmentation after three months of treatment with cyclosporine A.
format Online
Article
Text
id pubmed-10148980
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher OMJ
record_format MEDLINE/PubMed
spelling pubmed-101489802023-05-01 Cyclosporine A-induced Hair Repigmentation in a Patient with Dermatitis: A Case Report Al Rajaibi, Raqiya Al Saadi, Balaqis Oman Med J Case Reports Cyclosporine A is an immunosuppressant drug known to cause several side effects. One of the most common side effects is hypertrichosis, with a rare presentation of hair repigmentation rarely presenting. Here, we report a case of a 65-year-old Omani male who presented to the dermatology clinic at Rustaq Polyclinic in Rustaq, Oman, with exfoliative erythroderma. The patient had hair repigmentation after three months of treatment with cyclosporine A. OMJ 2023-03-31 /pmc/articles/PMC10148980/ /pubmed/37132003 http://dx.doi.org/10.5001/omj.2023.15 Text en The OMJ is Published Bimonthly and Copyrighted 2023 by the OMSB. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) 4.0 License. http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Case Reports
Al Rajaibi, Raqiya
Al Saadi, Balaqis
Cyclosporine A-induced Hair Repigmentation in a Patient with Dermatitis: A Case Report
title Cyclosporine A-induced Hair Repigmentation in a Patient with Dermatitis: A Case Report
title_full Cyclosporine A-induced Hair Repigmentation in a Patient with Dermatitis: A Case Report
title_fullStr Cyclosporine A-induced Hair Repigmentation in a Patient with Dermatitis: A Case Report
title_full_unstemmed Cyclosporine A-induced Hair Repigmentation in a Patient with Dermatitis: A Case Report
title_short Cyclosporine A-induced Hair Repigmentation in a Patient with Dermatitis: A Case Report
title_sort cyclosporine a-induced hair repigmentation in a patient with dermatitis: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148980/
https://www.ncbi.nlm.nih.gov/pubmed/37132003
http://dx.doi.org/10.5001/omj.2023.15
work_keys_str_mv AT alrajaibiraqiya cyclosporineainducedhairrepigmentationinapatientwithdermatitisacasereport
AT alsaadibalaqis cyclosporineainducedhairrepigmentationinapatientwithdermatitisacasereport